It is part of an ongoing nationwide cohort established in 1997, which includes data from over 50 000 members of families with an increased risk of breast cancer and/or ovarian cancer, who were tested primarily for BRCA1 and BRCA2 genetic variants. The gene discussed is BRCA2; the disease is breast cancer.